Sedana Medical AB (publ)

BATS-CHIXE:SEDANS Stock Report

Market Cap: SEK 2.3b

Sedana Medical Management

Management criteria checks 2/4

Sedana Medical's CEO is Johannes Doll, appointed in Oct 2021, has a tenure of 2.92 years. total yearly compensation is SEK5.24M, comprised of 62.2% salary and 37.8% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth SEK2.74M. The average tenure of the management team and the board of directors is 2.4 years and 2.3 years respectively.

Key information

Johannes Doll

Chief executive officer

SEK 5.2m

Total compensation

CEO salary percentage62.2%
CEO tenure2.9yrs
CEO ownership0.1%
Management average tenure2.4yrs
Board average tenure2.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Johannes Doll's remuneration changed compared to Sedana Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-SEK 41m

Mar 31 2024n/an/a

-SEK 23m

Dec 31 2023SEK 5mSEK 3m

-SEK 60m

Sep 30 2023n/an/a

-SEK 57m

Jun 30 2023n/an/a

-SEK 58m

Mar 31 2023n/an/a

-SEK 71m

Dec 31 2022SEK 5mSEK 3m

-SEK 74m

Sep 30 2022n/an/a

-SEK 54m

Jun 30 2022n/an/a

-SEK 62m

Mar 31 2022n/an/a

-SEK 68m

Dec 31 2021SEK 5mSEK 1m

-SEK 58m

Compensation vs Market: Johannes's total compensation ($USD512.74K) is below average for companies of similar size in the UK market ($USD770.39K).

Compensation vs Earnings: Johannes's compensation has increased whilst the company is unprofitable.


CEO

Johannes Doll (43 yo)

2.9yrs

Tenure

SEK 5,244,000

Compensation

Mr. Johannes Doll serves as Chief Executive Officer and President at Sedana Medical AB (publ) since October 01, 2021. Mr. Doll had been Executive Vice President and Chief Commercial Officer at Orexo AB (pu...


Leadership Team

NamePositionTenureCompensationOwnership
Johannes Doll
CEO & President2.9yrsSEK 5.24m0.12%
SEK 2.7m
Johan Spetz
Chief Financial Officer2.4yrsno data0.12%
SEK 2.7m
Karolina Vilval
General Counsel2.1yrsno datano data
Peter Sackey
Chief Medical Officer6.7yrsno data0.23%
SEK 5.3m
Linda Frölén
Head of Group Financeno datano datano data
Anders Ersson
Head of International Markets2.3yrsno data0.0050%
SEK 116.2k
Clarisa Mogollón
Chief Commercial Officerless than a yearno datano data
Jessica Westfal
VP of Regulatory Affairs and QA4.3yrsno data0.00070%
SEK 16.2k
Uwe Veismann
GM for Germany1.2yrsno datano data
Stefan Krisch
Supply Chain & Manufacturing Director3.5yrsno data0.0056%
SEK 130.3k

2.4yrs

Average Tenure

47yo

Average Age

Experienced Management: SEDANS's management team is considered experienced (2.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Claus Bjerre
Independent Chairman of the Board3.3yrsSEK 545.00kno data
Donna Haire
Directorless than a yearno datano data
Jens Viebke
Independent Directorless than a yearno datano data
Hilde Furberg
Independent Director2.3yrsSEK 242.00k0.0045%
SEK 104.6k
Christoffer Rosenblad
Independent Director4.3yrsSEK 317.00k0.010%
SEK 232.6k

2.3yrs

Average Tenure

55yo

Average Age

Experienced Board: SEDANS's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.